BioSpace News Archive

West Pharmaceutical Services, Inc. announced its financial results for the fourth-quarter and full-year 2023 and introduced full-year 2024 financial guidance.

Aurinia Pharmaceuticals Inc. provided an update on its 2023 fourth quarter and full year business performance, as well as a corporate update regarding the Company’s strategic review.

Kymera Therapeutics, Inc. will report fourth quarter and full year 2023 financial results on February 22, 2024, and will host a conference call at 8:30 a.m. ET.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, reported business highlights and financial results for the fourth quarter and year ended December 31, 2023.

Renalytix plc, an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease, reported financial results for the fiscal second quarter ended December 31, 2023.

Applied Therapeutics, Inc. announced positive interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary endpoints and several key secondary endpoints were achieved.

Compugen Ltd., a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024.

Ionis Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug designation to the investigational medicine olezarsen for the treatment of familial chylomicronemia syndrome, a rare, genetic disease characterized by extremely elevated triglyceride levels and recurrent acute pancreatitis.

Labcorp, a global leader of innovative and comprehensive laboratory services, announced results for the fourth quarter and year ending Dec. 31, 2023, and full year 2024 guidance.

SkyWater Technology, the trusted technology realization partner, announced it has signed a production agreement with Nautilus Biotechnology, Inc. to supply silicon-based microfluidic bio chips for Nautilus’ proteome analysis system.